Progyny Inc reports results for the quarter ended June 30 - Earnings Summary

• Progyny Inc PGNY.OQ reported quarterly adjusted earnings of 19 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 17 cents. The mean expectation of ten analysts for the quarter was for earnings of 16 cents per share. Wall Street expected results to range from 15 cents to 20 cents per share.

• Revenue rose 9.5% to $332.87 million from a year ago; analysts expected $320.08 million.

• Progyny Inc's reported EPS for the quarter was 19 cents​.

• The company reported quarterly net income of $17.11 million.

• Progyny Inc shares had risen by 6.8% this quarter and gained 36.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is also "buy"

• Wall Street's median 12-month price target for Progyny Inc is $28.00, about 17.6% above its last closing price of $23.06

This summary was machine generated from LSEG data August 8 at 03:53 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)